Kirin Holdings Co. (OTCMKTS:KNBWY – Get Free Report)’s share price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $18.52 and traded as high as $18.53. Kirin shares last traded at $18.45, with a volume of 17,218 shares changing hands.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Kirin from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Kirin currently has a consensus rating of “Hold”.
Check Out Our Latest Report on Kirin
Kirin Stock Performance
The stock has a market cap of $14.95 billion, a PE ratio of 11.75 and a beta of 0.01. The stock has a fifty day simple moving average of $18.52 and a two-hundred day simple moving average of $17.55. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.02 and a current ratio of 1.48.
Kirin (OTCMKTS:KNBWY – Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.16. Kirin had a net margin of 7.79% and a return on equity of 12.22%. The company had revenue of $4.08 billion for the quarter, compared to analyst estimates of $3.87 billion. Equities analysts anticipate that Kirin Holdings Co. will post 1.34 EPS for the current fiscal year.
About Kirin
Kirin Holdings Company, Limited is a Japan-based diversified food and beverage company best known for its beer and other alcoholic beverages. Through its beverage businesses, the company offers beer, sparkling alcoholic drinks, wine, soft drinks, tea and coffee products, including well-known brands such as Kirin Ichiban Shibori, Kirin Lager, Hyoketsu and Gogo no Kocha.
The company also operates in pharmaceuticals and health science. Its pharmaceutical activities have included the development and commercialization of prescription medicines, while its health science business focuses on products and technologies related to wellness and human health.
Featured Articles
- Five stocks we like better than Kirin
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
